Longevity isn't supplements and biohacking trends. It's the protocols, biomarkers, and lab work that compound across decades. Healthspan, not just lifespan. Coverage focused on what holds up across long-term evidence.
Longevity research is the youngest and most contested area we cover. We're cautious — the field is full of charismatic figures making claims ahead of evidence. Our coverage prioritizes what holds up across long-term human studies, with explicit acknowledgment of uncertainty where it exists.
Five sub-topics organize our coverage of longevity. Articles publish weekly under these themes.
Which lab values actually predict longevity outcomes
Annual panels, what to test, how to interpret
Caloric restriction, exercise, sleep — the validated levers
Rapamycin, NAD+, metformin — separating evidence from hype
ApoB, lipids, and the biggest determinant of healthspan
New articles published weekly. Subscribe to the newsletter for first access — typically 24-48 hours before public publication.
We publish 2-3 articles per week per pillar. Subscribe to be notified when new longevity articles drop, or check back weekly.
Subscribe to the Friday briefOne concise email every Friday. The week's research in longevity and the other four pillars, tools worth your money, protocols worth testing.